We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$984M
AUM Growth
+$75.1M
Cap. Flow
+$13.9M
Cap. Flow %
1.41%
Top 10 Hldgs %
54.55%
Holding
135
New
7
Increased
20
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.77M
2
GIS icon
General Mills
GIS
+$4.51M
3
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$3.41M
4
JNJ icon
Johnson & Johnson
JNJ
+$3.27M
5
KHC icon
Kraft Heinz
KHC
+$3.04M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$11.9M
2
AMGN icon
Amgen
AMGN
+$2.76M
3
GILD icon
Gilead Sciences
GILD
+$2.63M
4
BIIB icon
Biogen
BIIB
+$1.96M
5
CELG
Celgene Corp
CELG
+$1.61M

Sector Composition

Rank Sector Weight
1 Financials 35.78%
2 Healthcare 22.27%
3 Industrials 11.22%
4 Technology 7.01%
5 Consumer Staples 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPHS
76
DELISTED
Sophiris Bio, Inc.
SPHS
$474K 0.05%
+170,000
New +$484K
BDSI
77
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$420K 0.04%
150,000
-91,567
-38% -$257K
GTN icon
78
Gray Television
GTN
$490M
$383K 0.04%
21,890
– –
PINC
79
DELISTED
Premier
PINC
$375K 0.04%
8,200
– –
OMC icon
80
Omnicom Group
OMC
$23.6B
$374K 0.04%
5,500
– –
ABEO icon
81
Abeona Therapeutics
ABEO
$422M
$360K 0.04%
1,124
-200
-15% -$70.9K
AMCX icon
82
AMC Global Media
AMCX
$486M
$337K 0.03%
5,080
– –
FFIV icon
83
F5
FFIV
$23.4B
$331K 0.03%
1,660
– –
CA
84
DELISTED
CA, Inc.
CA
$331K 0.03%
7,490
– –
ECL icon
85
Ecolab
ECL
$79.8B
$329K 0.03%
2,100
– –
ALSN icon
86
Allison Transmission
ALSN
$10.3B
$324K 0.03%
6,220
– –
GYRE icon
87
Gyre Therapeutics
GYRE
$704M
$323K 0.03%
+4,000
New +$317K
KBR icon
88
KBR
KBR
$4.74B
$318K 0.03%
15,040
– –
CI icon
89
Cigna
CI
$72.4B
$312K 0.03%
1,500
– –
ELV icon
90
Elevance Health
ELV
$84.7B
$312K 0.03%
1,140
– –
HCC icon
91
Warrior Met Coal
HCC
$5.16B
$311K 0.03%
11,500
– –
RMR icon
92
The RMR Group
RMR
$337M
$307K 0.03%
3,310
– –
MSGN
93
DELISTED
MSG Networks Inc.
MSGN
$298K 0.03%
11,540
– –
CHKP icon
94
Check Point Software Technologies
CHKP
$13.2B
$295K 0.03%
2,510
– –
UTHR icon
95
United Therapeutics
UTHR
$22.1B
$294K 0.03%
2,300
– –
ORCL icon
96
Oracle
ORCL
$419B
$289K 0.03%
5,600
– –
BFH icon
97
Bread Financial
BFH
$4.36B
$288K 0.03%
1,529
– –
TGNA
98
DELISTED
TEGNA Inc
TGNA
$285K 0.03%
23,790
– –
CNNE icon
99
Cannae Holdings
CNNE
$652M
$281K 0.03%
13,400
– –
HOLX
100
DELISTED
Hologic
HOLX
$281K 0.03%
6,850
– –
2 3
4
5 6

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2018 Portfolio in Review

As of Q3 2018, Hikari Power held 135 positions worth $984M, up 8.3% from $908M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Hikari Power's Q3 2018 filing shows 7 new, 20 increased, 9 reduced and 8 closed positions. Its largest new stake was Bank of New York Mellon: 25,300 shares worth $1.29M. The largest sale was IBM, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q3 2018 buy was Bank of New York Mellon: 25,300 shares worth $1.29M.
  • Hikari Power added most to Allergan plc in Q3 2018, an estimated $6.77M increase.
  • Hikari Power's biggest Q3 2018 reduction was IBM, cutting an estimated $11.9M.
  • Hikari Power fully exited Acadia Pharmaceuticals in Q3 2018, selling an estimated $916K.
  • Hikari Power's ten largest holdings make up 55% of its $984M portfolio in Q3 2018.
  • Hikari Power opened 7 new positions and closed 8 in Q3 2018.
  • Hikari Power's portfolio value rose 8.3% quarter-over-quarter to $984M.

Based on Hikari Power's 13F filing for Q3 2018, filed 31 Oct 2018.